By: Scott T. Tagawa, Benjamin P. Levy
Drs Levy and Tagawa discuss the rapidly evolving treatment paradigms for prostate cancer and RCC live at the 43rd Annual Chemotherapy Foundation Symposium.
United States (National)
Benjamin P. Levy
Geo Focus
Coverage Attributes:
Beta
Interviews Q&as:
25
%
Events:
25
%
Data Driven:
25
%
Informative:
25
%
Themes Covered:
Not enough data
Pitching Insights
Benjamin P. Levy's coverage prominently focuses on healthcare and pharmaceuticals, particularly in the context of cancer treatment with a specific emphasis on NSCLC (non-small cell lung cancer), antibody-drug conjugates, biomarker testing, and gastric cancer.
Given this focus, he is likely to be most responsive to pitches that offer expert commentary from professionals deeply involved in the development or application of oncology treatments such as researchers, clinicians specializing in lung cancer treatment, pharmaceutical industry experts or patient advocates.
As Benjamin’s articles cite data extensively and delve into industry-specific details related to healthcare and biotechnology topics like clinical trials or drug developments, tailored pitches offering new research findings or insights into emerging treatments are more likely to resonate with him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Assistant Managing Editor
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Assistant Editor
Publications
Most recent topics
Not enough data
Senior Editor
Publications
Most recent topics
Not enough data
